Enveda – Talk Bio

Actionable Insights Powered by AI

Enveda Raises $150M Series D, Advances Nature-Inspired Drug Programs

2 months ago talkbio0Tagged Biosciences, Dermatitis, Atopic, Enveda, Immune System Diseases, Investments, Mikael, nature-inspired drug discovery, Series D

Enveda Biosciences; Series D funding; $150 million; nature-inspired drug discovery; atopic dermatitis; immune diseases; Mikael Dolsten; biotech investment

Enveda Secures $130 Million in Funding for Innovative Therapies in Inflammation, Obesity, and Beyond

11 months ago talkbio0Tagged Drug Development, Enveda, I&I, Inflammation, Microsoft-backed, Obesity, Pharma

Enveda, Microsoft-backed, $130M funding, Inflammation & Immunology (I&I), obesity, biotech, pharma, drug development